Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	168	164	73	202	497	293
Market Cap Growth	161.11%	126.02%	-64.04%	-59.37%	69.48%	56.45%
Enterprise Value	119	85	-69	134	386	227
PE Ratio	-	-1.00	-0.77	-2.33	-5.91	-3.89
PS Ratio	24.01	16.52	4.88	8.60	32.93	147.97
PB Ratio	11.13	9.85	0.57	2.37	5.49	3.70
P/FCF Ratio	-1.38	-1.51	-0.58	-2.00	-8.19	-4.03
P/OCF Ratio	-1.36	-1.50	-0.59	-2.03	-8.66	-4.87
EV/Sales Ratio	17.02	8.51	-4.65	5.69	25.59	114.77
EV/EBITDA Ratio	-0.68	-0.54	0.79	-1.68	-4.88	-3.13
EV/EBIT Ratio	-0.67	-0.53	0.76	-1.62	-4.70	-3.02
EV/FCF Ratio	-0.91	-0.78	0.56	-1.33	-6.36	-3.13
Debt / Equity Ratio	4.10	3.73	0.50	0.76	0.73	0.33
Debt / EBITDA Ratio	-0.45	-0.40	-0.73	-0.82	-0.84	-0.36
Debt / FCF Ratio	-0.60	-0.57	-0.51	-0.65	-1.09	-0.36
Quick Ratio	2.96	3.86	6.73	4.24	6.19	4.75
Current Ratio	3.01	3.95	6.87	4.34	6.24	4.87
Asset Turnover	0.04	0.06	0.07	0.11	0.09	0.02
Interest Coverage	-26.70	-31.10	-21.90	-21.15	-45.90	-1046.75
Return on Equity (ROE)	-409.20%	-282.60%	-108.00%	-73.50%	-122.00%	-86.30%
Return on Assets (ROA)	-91.50%	-93.70%	-46.90%	-39.10%	-51.30%	-56.50%
Return on Capital (ROIC)	-165.12%	-163.82%	-71.02%	-66.10%	-52.50%	-73.97%
Earnings Yield	-86.22%	-100.28%	-130.36%	-42.86%	-16.91%	-25.72%
FCF Yield	-61.07%	-66.06%	-171.19%	-49.91%	-12.21%	-24.82%
Buyback Yield / Dilution	-40.00%	-124.24%	-102.00%	-35.79%	-14.49%	-23.17%
Total Shareholder Return	-40.00%	-124.24%	-102.00%	-35.79%	-14.49%	-23.17%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).